Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy.
Clin Case Rep
; 9(10): e04935, 2021 Oct.
Article
em En
| MEDLINE
| ID: mdl-34721849
ABSTRACT
Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article